PKPavel KhaykinMDVideoViral Hepatitis and Liver Disease23rd European Meeting on HIV & Hepatitis 2025HCV Elimination: Why Do We Still Have Gaps and How Do We Close These Gaps? - Pavel KhaykinView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #17 Clonal Analysis of Near Full-Length Proviral HIV-1 Genome Enables Differentiation of APOBEC- and Drug-Resistant Populations in Highly Treatment Experienced People Living with HIV - Martin DäumerView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #15 Virologic Failure and Resistance Emergence During Treatment with B/F/TAF or DTG/3TC in PWH Without Prior Resistance Mutations: A Real-World Study - Thomas DrumelView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #14 Three-Years Outcome After Genotyping-Guided Switch in HIV Multi-Drug Resistant Patients in Cameroon: Evidence-Based Strategies for Achieving Epidemic Control in Low-and Middle-Income Countries - Ezechiel Ngoufack Jagni SemengueView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #13 Estimating the Genetic Barrier for Resistance to Integrase Inhibitors for the Most Frequently Circulating HIV-1 Subtypes - Mafalda N.S. MirandaView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #12 Increased Dynamics of Novel A6/B Recombinant Forms Emergence Following Full-Scale War in Ukraine - Karol SerwinView Video
FCFrancesca Ceccherini-SilbersteinPhDVideoHIVViral Hepatitis and Liver Disease23rd European Meeting on HIV & Hepatitis 2025How to Improve Fruitful Dialogue between the Virology Lab and Clinicians: Lab Manager Perspective - Francesca Ceccherini-SilbersteinView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #10 Resistance Analyses of F/TAF, F/TDF, and Lenacapavir in the PURPOSE 1 and 2 Studies – Stephanie CoxView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #9 Clearance of NNRTI Resistance-Associated Mutations in the HIV-1 DNA Reservoir with or Without the Presence of M184V Mutation - Anne-Geneviève MarcelinView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #8 Analysis of 16 Years of ARV Resistance Transmission in Newly Diagnosed HIV Cases in Spain (2007-2023): 2023 Update and the Impact of PrEP on M184V Detection - Paloma MuñozView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #7 Resistance Analysis of Long-Acting Lenacapavir in Heavily Treatment-Experienced People with HIV After 3 Years of Lenacapavir Treatment - Nicolas MargotView Video
VideoHIV23rd European Meeting on HIV & Hepatitis 2025Abstract #6 Lenacapavir Resistance Profile in Heavily Treatment-Experienced People in the PRESTIGIO Registry - Maria Mercedes SantoroView Video
